Contact Us
Drug Search Results
More Filters [+]

Argatroban

Alternative Names: argatroban, argatroban in 0.9% sodium chloride
Latest Update: 2024-12-12
Latest Update Note: Clinical Trial Update

Product Description

Argatroban is a medication used to manage heparin-induced thrombocytopenia (HIT), which is a rare, life-threatening complication of heparin therapy. It is a direct thrombin inhibitor, a class of anticoagulant drugs.  (Sourced from: https://www.ncbi.nlm.nih.gov/books/NBK555971/)

Mechanisms of Action: DT Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Approved

Approved Countries: Austria | Canada | China | Denmark | Egypt | Finland | France | Germany | Greece | India | Italy | Japan | Korea | Malta | Netherlands | Norway | Romania | Saudi Arabia | Spain | Sweden | Switzerland | Turkey | United Kingdom | United States

Approved Indications: Coronary Thrombosis | Thrombosis | Thrombocytopenia | Coronary Thrombosis | Thrombosis | Thrombocytopenia

Known Adverse Events: Cardiac Arrest | Hypotension | Back Pain | Chest Pain | Headache | Pain Unspecified | Dyspnea | Diarrhea | Sepsis

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Argatroban

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title

10/05/2023

News Article

 Elixir Medical To Present Randomized Clinical Dataset Featuring World's First Triple Drug-Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus at TCT 2023

09/25/2023

News Article

 Argatroban Market Size and Overview Featuring Key Players and Top Country Data

09/14/2023

News Article

 Argatroban Market 2023 Global Demand and Emerging Trends by 2031- Pfizer, Inc, SANDOZ, GlaxoSmithKline Plc, fresenius-kabi, Eagle Pharmaceuticals

04/17/2023

News Article

 Endo Announces Launch of Argatroban Injection Through Premier's ProRx® Private-Label Program

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions